Strategic partnerships Niramai has a history of collaborating with major healthcare providers and patient advocacy groups (Medanta, Apollo Clinics, HCG, Healthians, Action Pink), indicating a strong channel for co-branded screening programs, mobile vans, and home screening services that could be expanded with enterprise hospital networks and private clinics.

Expanded accessibility Recent launches of Mobile Screening Van and Home Screenings demonstrate a focus on outreach and accessibility. Opportunities exist to offer employer health programs, gated communities, and government or NGO initiatives that require scalable, non-invasive screening solutions.

Innovation leverage Thermalytix is a proprietary AI-driven breast cancer screening technology with ongoing recognition (international patents, awards). Potential sales angles include licensing to radiology partners, integration with existing hospital IT systems, and white-label solutions for larger health networks.

Publicity and credibility Awards and high-profile partnerships position Niramai as a trusted innovator in breast health. Use these credentials in proposals to health systems, insurers, and government programs to accelerate adoption and secure multi-site contracts.

Growth-ready financing Revenue range indicates early-stage scale with international patent footprint and a diversified deployment model. Target mid to large hospital groups, diagnostic chains, and payers looking to reduce screening costs and increase early detection through AI-powered screening.